BigHat Biosciences
BigHat Biosciences is a company with a mission to enhance human health by making it easier to design advanced antibody therapeutics.
3
Funding Rounds
$99.3m
Money raised
Overview
BigHat Biosciences is a company with a mission to enhance human health by making it easier to design advanced antibody therapeutics.
-
Website:
- Business model: B2C
- Social accounts:
Funding series
Funding Series Analysis
The company BigHat Biosciences has raised a total of $75m in funding over 3 rounds.
Key Insights:
- BigHat Biosciences Series B round, July 20, 2022: $75m
- BigHat Biosciences Series A round, February 2021: $19m
- BigHat Biosciences Seed round, December 2019: $5.3m
BigHat Biosciences Series B round, July 20, 2022
$75m
BigHat Biosciences Series A round, February 2021
$19m
BigHat Biosciences Seed round, December 2019
$5.3m
Industries
BigHat Biosciences is active in the following industries: